Related Experiment Video
Updated: Jun 30, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Expression, purification, and functional characterization of recombinant human interleukin-7
Yong Luo1, Xiangping Kong, Aimin Xu
1Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Science Park, Guangzhou 510663, China.
Protein Expression and Purification
|September 23, 2008
Summary
This study produced bioactive recombinant human interleukin-7 (rhIL-7) in yeast, achieving high yields and purity. This method offers a simpler, scalable approach for producing rhIL-7 for research and clinical use.
Area of Science:
- Biotechnology
- Immunology
- Protein Expression
Background:
- Human interleukin-7 (IL-7) is crucial for immune cell development and has therapeutic potential.
- Previous prokaryotic expression systems for IL-7 faced limitations due to low recovery rates from refolding steps.
- A need exists for efficient and scalable production methods for bioactive recombinant human IL-7 (rhIL-7).
Purpose of the Study:
- To develop a eukaryotic expression system for producing high-yield, bioactive rhIL-7.
- To establish a simplified purification strategy for rhIL-7.
- To assess the feasibility of yeast-based production for clinical and research applications.
Main Methods:
- Cloning of human IL-7 cDNA and expression in the Pichia pastoris yeast system.
- Development of a straightforward purification protocol from fermentation supernatant.
- Purification using SP Sepharose FF cation-exchange chromatography.
- Functional assessment via pre-B cell proliferation assay (MTT).
Main Results:
- Successful expression of active rhIL-7 in Pichia pastoris.
- Achieved a yield of 35 mg/L with 95% purity using cation-exchange chromatography.
- Purified rhIL-7 exhibited specific activity comparable to commercial standards.
- Demonstrated the efficacy of the yeast expression and purification strategy.
Conclusions:
- Yeast expression in Pichia pastoris is an effective strategy for producing bioactive rhIL-7.
- The developed purification method is simple and yields high-purity protein.
- This approach supports large-scale rhIL-7 production for clinical applications and fundamental research.

